FIELD: pharmaceutical industry.
SUBSTANCE: new urogenital drug contains 50-250 g antibacterially efficient antibiotic erythromycin, 50-250 g antifungally efficient antibiotic nistatin, antiprotozoal preparation metronidazole, and 1.5-3.5 g (to complete weight of suppository) A type solid fat as filler. Drug can be used to treat mixed urogenital infections.
EFFECT: reduced treatment time, lowered recurrence of diseases, lack of adverse effects, and lowered cost.
| Title | Year | Author | Number |
|---|---|---|---|
| PHARMACEUTICAL COMPOSITION FOR LOCAL APPLICATION IN GYNAECOLOGY | 2010 |
|
RU2454233C2 |
| METHOD FOR TREATMENT OF RELAPSING UROGENITAL CANDIDIASIS ON BACKGROUND OF TRICHOMONIASIS | 2001 |
|
RU2212238C2 |
| MEDICINAL PREPARATION AND METHOD OF UROGENITAL INFECTION PROPHYLAXIS AND TREATMENT | 1996 |
|
RU2073520C1 |
| VAGINAL SUPPOSITORY | 2006 |
|
RU2320319C1 |
| METHOD OF TREATING CERVICAL ECTOPIA | 2014 |
|
RU2568768C1 |
| AGENT AND METHOD FOR TREATMENT OF BACTERIAL VAGINITIS | 2004 |
|
RU2261715C1 |
| MEDICINAL AGENT ANTIPROTOZOAL WITH RESPECT TO TRICHOMONAS VAGINALIS IN MODEL SYSTEM IN VITRO | 2008 |
|
RU2366442C1 |
| METHOD OF TREATMENT OF PATIENTS WITH UROGENITAL CHLAMYDIUM, UREAPLASMA AND MYCOPLASMA INFECTION | 1995 |
|
RU2137483C1 |
| METHOD OF TREATING PATIENTS WITH CHRONIC ENDOMETRITIS AND TUBAL AND PERITONEAL INFERTILITY FACTOR | 2014 |
|
RU2557957C1 |
| METHOD FOR ELIMINATING ATOPOBIUM VAGINAE BACTERIA IN TREATING BACTERIAL VAGINOSIS | 2010 |
|
RU2445964C2 |
